Rocket Pharmaceuticals Inc at Morgan Stanley Healthcare Conference Transcript
Good morning, and thank you very much for coming to the Morgan Stanley Healthcare Conference. Before I get going, let me read the requisite disclosures. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, appear on the Morgan Stanley public website at www.morganstanley.com/researchdisclosures or at the registration desk.
I'm Dave Lebowitz, one of the biotechnology analysts here, and I'm happy to have with me from Rocket Pharmaceuticals, CEO, Dr. Gaurav Shah. Rocket is a development-stage gene therapy company and developing treatments for rare diseases. So I guess if you could start by giving a background of the company and your overall approach to developing gene therapies and the mission.
Sure. Thanks for having me here. It's been a year. We're just talking about this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |